نتائج البحث

A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated Approach (DISBAND)

• Source: A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated Approach

تفاصيل العنوان

Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation

• Source: Natural History and Biomarkers of C9ORF72 Amyotrophic Lateral Sclerosis and Frontotemporal DementiaKrishnan G, Raitcheva D, Bartlett

تفاصيل العنوان

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

• Source: Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal DementiaSnowden JS,

تفاصيل العنوان

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants with Frontotemporal Dementia (FTD-GRN)

• Authors : Takeda

• Source: A Phase 1/2, Multicenter, Randomized, Placebo-Controlled, Double Blind Single Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in

تفاصيل العنوان

Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia

• Authors : National Institute on Aging (NIA)

• Source: Functional Neuroimaging to Examine Affective Symptoms and Cognition in Frontotemporal Dementia

تفاصيل العنوان

Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial (PEA-FTD)

• Source: Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial

تفاصيل العنوان

Study of How VES001 Works and How Safe it is to Participants With GRN-frontotemporal Dementia Showing no Symptoms (SORT-IN-2)

• Authors : Mads Kjolby, Chief Medical Officer

• Source: Open-label Multiple Dosing Study in Asymptomatic GRN-frontotemporal Dementia Patients to Investigate the Safety, Tolerability,

تفاصيل العنوان

Dopaminergic Therapy for Frontotemporal Dementia Patients

• Authors : Alzheimer's Drug Discovery Foundation; Giacomo Koch, Prof

• Source: Dopaminergic Therapy for Frontotemporal Dementia Patients: an Interventional, Multi-site, Randomized, Double-blind, Placebo-controlled

تفاصيل العنوان

A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

• Source: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of AL001 in Individuals At Risk for or with Frontotemporal

تفاصيل العنوان

A Study of PBFT02 in Patients With Frontotemporal Dementia and Progranulin Mutations (FTD-GRN) (upliFT-D)

• Source: A Phase 1b Open-Label, Multicenter, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacodynamic Effects of a Single Dose of PBFT02 Delivered Into the Cisterna Magna of Adult Subjects

تفاصيل العنوان